The invention provides compounds which are useful as inhibitors of
metalloproteases, and which are effective in treating conditions
characterized by excess activity of these enzymes. In particular, the
present invention relates to a compound having a structure according to
Formula (I). 1
Also disclosed are compounds, pharmaceutical compositions and methods of
treating diseases characterized by metalloprotease activity using these
compounds or the pharmaceutical compositions containing them.
